Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Bionoid Pharma Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.25 |
52 Week High | US$1.04 |
52 Week Low | US$0.062 |
Beta | 0 |
1 Month Change | 25.00% |
3 Month Change | -51.92% |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | -98.00% |
Change since IPO | -99.99% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
BINP | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | 0.3% | 3.3% |
1Y | n/a | 12.0% | 25.0% |
Return vs Industry: Insufficient data to determine how BINP performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how BINP performed against the US Market.
Price Volatility
BINP volatility | |
---|---|
BINP Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 10.0% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.5% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BINP's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine BINP's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | bionoidpharma.com |
Bionoid Pharma Inc. engages in the hemp cultivation business. The company is based in Beverly Hills, California.
Bionoid Pharma Inc. Fundamentals Summary
BINP fundamental statistics | |
---|---|
Market cap | US$13.50m |
Earnings (TTM) | -US$1.62m |
Revenue (TTM) | US$92.26k |
0.0x
P/S Ratio0.0x
P/E RatioIs BINP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BINP income statement (TTM) | |
---|---|
Revenue | US$92.26k |
Cost of Revenue | US$44.77k |
Gross Profit | US$47.48k |
Other Expenses | US$1.67m |
Earnings | -US$1.62m |
Last Reported Earnings
Dec 31, 2013
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did BINP perform over the long term?
See historical performance and comparison